PlainRecalls
FDA Drug Moderate Class II Terminated

Proair, HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 59310-579-22

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1076-2022

Product Description

Proair, HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 59310-579-22

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
56 inhalers
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Proair, HFA (albuterol sulfate) Inhalation Aerosol 90 mcg per actuation, 200 metered inhalations, Rx only, MFG: Teva Pharma USA, NDC 59310-579-22. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 56 inhalers.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1076-2022.